P&G/Cygnus
This article was originally published in The Tan Sheet
Executive Summary
Announce agreement to develop an as-yet-unnamed consumer product using a Cygnus drug delivery system on Oct. 25. The product, which will not make use of a transdermal system, will be manufactured by Cygnus and marketed exclusively by P&G worldwide. Cygnus said the product is not expected to require FDA approval and that its controlled-release technologies are applicable for cough/sore throat medicines and nasal sprays as well as oral hygiene products. P&G plans to undertake consumer testing with prototypes of the product during the next year. Cygnus said it is currently negotiating with P&G and several other firms to develop additional consumer products, while P&G noted that it is in discussions with Cygnus regarding "several other delivery systems for a variety of markets".